Results 181 to 190 of about 620,040 (295)
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source
The Hidden Power of Humility: Elevating Patient and Provider Experience Through Clinician Self-Awareness and Patient-Centered Care. [PDF]
Rizzo M +3 more
europepmc +1 more source
Patient-Centered Care: “It’s the Patient, Stupid!” [PDF]
Goldfarb, Neil I., Shaller, Dale
core +1 more source
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen +14 more
wiley +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
Enhancing Collaboration and Patient-Centered Care Through Moderated Multidisciplinary Consultations. [PDF]
Hulbaek M, Edal BT, Thude BR.
europepmc +1 more source
Emerging strategies to target metastasis and therapy resistance in melanoma
Emerging studies propose new approaches to interfere with melanoma progression. In recognition of melanoma awareness month, at Molecular Oncology, we highlight recently published research articles, focusing on novel therapeutic targets driving metastatic spread and outlining different strategies to overcome resistance to BRAF inhibitors and anti‐PD‐1 ...
Amel Aziba
wiley +1 more source
Conceptual Model for the Integration of Marketing Strategies and Biomedical Innovation in Patient-Centered Care: Mixed Methods Study. [PDF]
Das Gupta A, Yadav Y.
europepmc +1 more source
Chemoresistance in bladder cancer: Macrophage recruitment associated with CXCL1, CXCL5 and CXCL8 expression is characteristic of Gemcitabine/Cisplatin (Gem/Cis) Non‐Responder tumors (right side) while Responder tumors did not show substantial tumor‐stromal crosstalk (left side). All biological icons are attributed to Bioicons: carcinoma, cancerous‐cell‐
Sophie Leypold +11 more
wiley +1 more source
Achieving patient centered care: Communication and cultural competence
Jaikrit Bhutani +2 more
doaj +1 more source

